Signet Therapeutics is based in Boston, Massachusetts. It has raised $31M in total funding. Latest round: Seed.
Signet Therapeutics funding overview
Signet Therapeutics is based in Boston, Massachusetts. Signet Therapeutics has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in February 2024. The round record for Signet Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include 5Y Capital, Yael Capital, Blue Ocean Capital, Tiantu Capital, Sky9 Capital. 5 distinct backers are named across the disclosed rounds.
Signet Therapeutics at a glance
Total raised
$31M
Latest round
Seed
Latest round date
February 2024
Headquarters
Boston, Massachusetts
Notable investors
5Y Capital, Yael Capital, Blue Ocean Capital, Tiantu Capital, Sky9 Capital
Frequently asked about Signet Therapeutics funding
How much has Signet Therapeutics raised?
Signet Therapeutics has raised $31M in total disclosed funding across the rounds on record.
Who has invested in Signet Therapeutics?
5Y Capital, Yael Capital, Blue Ocean Capital, Tiantu Capital, Sky9 Capital are named among the investors backing Signet Therapeutics.
What was the latest Signet Therapeutics funding round?
The most recent disclosed round is a Seed, announced in February 2024.
Where is Signet Therapeutics based?
Signet Therapeutics is based in Boston, Massachusetts.
When did Signet Therapeutics last raise?
The last disclosed Signet Therapeutics round closed in February 2024 at Seed.
Signet Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
